Isothalictrine



Compound IDCDAMM02313
Common nameIsothalictrine
IUPAC name4-[5-[(6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl)methyl]-2,3,4-trimethoxyphenoxy]-6-[(2,3-dimethoxyphenyl)methyl]-[1,3]dioxolo[4,5-f]isoquinoline
Molecular formulaC41H44N2O10

Experimental data

Retention time8.99
Adduct[M+Na]+
Actual mz747.289
Theoretical mz747.289
Error0.24
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.2435

Identifiers and class information

Inchi keyZMOQZKRVYQLURK-UHFFFAOYNA-N
SmilesN=1C=CC=2C=3OCOC3C(OC=4C=C(C(OC)=C(OC)C4OC)CC5C6=CC(OC)=C(OC)C=C6CCN5C)=CC2C1CC=7C=CC=C(OC)C7OC
SuperclassOrganoheterocyclic compounds
ClassIsoquinolines and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)4
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)13
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)1
Molecular weight (mol_MW)724.806
Computed dipole moment(dipole)4.449
Total solvent accessible surface area (SASA)968.287
Hydrophobic component of SASA (FOSA)696.376
Hydrophilic component of SASA (FISA)11.649
Pie component of the SASA (PISA)260.263
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2023.38
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)10.25
Free energy of solvation of dipole (dip^2/V)0.0097846
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.798998
Predicted polarizability in cubic angstroms (QPpolrz)68.96
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.542
Predicted octanol/gas partition coefficient (QPlogPoct)28.403
Predicted water/gas partition coefficient (QPlogPw)11.127
Predicted octanol/water partition coefficient (QPlogPo/w)7.201
Predicted aqueous solubility (QPlogS)-5.863
Conformation-independent predicted aqueous solubility (CIQPlogS)-10.502
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.752
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1915.71
Predicted brain/blood partition coefficient (QPlogBB)0.057
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1105.08
Predicted skin permeability, log Kp (QPlogKp)-1.632
PM3 calculated ionization potential (IP(ev))8.485
PM3 calculated electron affinity (EA(eV))0.869
Number of likely metabolic reactions (#metab)13
Prediction of binding to human serum albumin (QPlogKhsa)1.198
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)88.982
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)93.19
Number of nitrogen and oxygen atoms (#NandO)12
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P13726F3Coagulation factor VII/tissue factorT72702SEA
P21728DRD1Dopamine D1 receptorT22118SEA
P21918DRD5Dopamine D5 receptorT46828SEA
P08581METHepatocyte growth factor receptorT40474SEA
P49286MTNR1BMelatonin receptor 1BT48268SEA
Q92952KCNN1Small conductance calcium-activated potassium channel protein 1T11911SEA
Q9UGI6KCNN3Small conductance calcium-activated potassium channel protein 3T04388SEA
Q9H2S1KCNN2Small conductance calcium-activated potassium channel protein 2T86271SEA
P54750PDE1APhosphodiesterase 1AT81637SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T72702DI0075Cervical cancer[ICD-11: 2C77]P13726F3
T22118DI0003Abortion[ICD-11: JA00]P21728DRD1
T22118DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]P21728DRD1
T22118DI0190Hypertension[ICD-11: BA00-BA04]P21728DRD1
T22118DI0331Parkinsonism[ICD-11: 8A00]P21728DRD1
T46828DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]P21918DRD5
T40474DI0238Lung cancer[ICD-11: 2C25]P08581MET
T40474DI0303Non-small-cell lung cancer[ICD-11: 2C25]P08581MET
T40474DI0407Thyroid cancer[ICD-11: 2D10]P08581MET
T48268DI0214Insomnia[ICD-11: 7A00-7A0Z]P49286MTNR1B
T11911DI0285Myelopathy[ICD-11: 8B42]Q92952KCNN1
T04388DI0285Myelopathy[ICD-11: 8B42]Q9UGI6KCNN3
T86271DI0285Myelopathy[ICD-11: 8B42]Q9H2S1KCNN2

Copyright © 2025